TY - JOUR AU - Vizi, E. Szilveszter TI - Dr. Paszternák Alfréd professzor (1930–2023) JF - ORVOSI HETILAP J2 - ORV HETIL VL - 164 PY - 2023 IS - 31 SP - 1235 EP - 1237 PG - 3 SN - 0030-6002 DO - 10.1556/650.2023.HO2766 UR - https://m2.mtmt.hu/api/publication/34131761 ID - 34131761 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Huang, Lumei AU - Mut-Arbona, Paula AU - Varga, Bernadett AU - Török, Bibiána AU - Brunner, János AU - Arszovszki, Antónia AU - Iring, András AU - Kisfali, Máté AU - Vizi, E. Szilveszter AU - Sperlágh, Beáta TI - P2X7 purinergic receptor modulates dentate gyrus excitatory neurotransmission and alleviates schizophrenia-like symptoms in mouse JF - ISCIENCE J2 - ISCIENCE VL - 26 PY - 2023 IS - 9 PG - 24 SN - 2589-0042 DO - 10.1016/j.isci.2023.107560 UR - https://m2.mtmt.hu/api/publication/34109310 ID - 34109310 LA - English DB - MTMT ER - TY - JOUR AU - Al-Khrasani, Mahmoud AU - Karádi, Dávid Árpád AU - Galambos, Anna Rita AU - Sperlágh, Beáta AU - Vizi, E. Szilveszter TI - The Pharmacological Effects of Phenylephrine are Indirect, Mediated by Noradrenaline Release from the Cytoplasm JF - NEUROCHEMICAL RESEARCH J2 - NEUROCHEM RES VL - 47 PY - 2022 IS - 11 SP - 3272 EP - 3284 PG - 13 SN - 0364-3190 DO - 10.1007/s11064-022-03681-2 UR - https://m2.mtmt.hu/api/publication/33062017 ID - 33062017 N1 - Department of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvárad tér 4., Budapest, 1089, Hungary Institute of Experimental Medicine, Eötvös Lóránd Research Network, Szigony utca 43., Budapest, 1083, Hungary Export Date: 9 November 2022 CODEN: NERED Correspondence Address: Vizi, E.S.; Department of Pharmacology and Pharmacotherapy, Nagyvárad tér 4., Hungary; email: esvizi@koki.hu Chemicals/CAS: calcium ion, 14127-61-8; cocaine, 50-36-2, 53-21-4, 5937-29-1; nisoxetine, 53179-07-0, 57754-86-6; noradrenalin, 1407-84-7, 51-41-2; phenylephrine, 532-38-7, 59-42-7, 61-76-7; prazosin, 19216-56-9, 19237-84-4; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Norepinephrine; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha-1 Funding details: Semmelweis Egyetem, TKP2021-EGA-25 Funding details: Emberi Eroforrások Minisztériuma, EMMI Funding text 1: Open access funding provided by Semmelweis University. This work was supported by Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Neurology Thematic Programme of Semmelweis University (TKP 2021 EGA-25). E. Sylvester Vizi has received research support from the Eötvös Lóránd Research Network. LA - English DB - MTMT ER - TY - JOUR AU - Némethy, Zsolt AU - Kiss, Béla AU - Lethbridge, Natasha AU - Chazot, Paul AU - Hajnik, Tünde AU - Tóth, Attila István AU - Détári, László AU - Schmidt, Éva AU - Czurkó, András AU - Kostyalik, Diána AU - Oláh, Vilmos AU - Hernádi, István AU - Balázs, Ottilia AU - Vizi, E. Szilveszter AU - Ledneczki, István AU - Mahó, Sándor AU - Román, Viktor AU - Lendvai, Balázs AU - Lévay, György István TI - Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist/inverse agonist JF - EUROPEAN JOURNAL OF PHARMACOLOGY J2 - EUR J PHARMACOL VL - 916 PY - 2022 PG - 17 SN - 0014-2999 DO - 10.1016/j.ejphar.2021.174621 UR - https://m2.mtmt.hu/api/publication/32555195 ID - 32555195 N1 - Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary Department of Biosciences, Durham University, Durham, UK, United Kingdom Department of Physiology and Neurobiology, Eötvös Loránd University, Budapest, Hungary Department of Experimental Zoology and Neurobiology, Faculty of Sciences, Grastyán Translational Research Center and Szentágothai Research Center, University of Pécs, Pécs, Hungary Institute of Experimental Medicine, Budapest, Hungary Export Date: 17 November 2023 CODEN: EJPHA Correspondence Address: Némethy, Z.; Laboratory of Systems Biology, P.O. Box 27, Hungary; email: nemethy@richter.hu LA - English DB - MTMT ER - TY - JOUR AU - Román, Viktor AU - Kedves, Rita AU - Kelemen, Kristóf AU - Némethy, Zsolt AU - Sperlágh, Beáta AU - Lendvai, Balázs AU - Vizi, E. Szilveszter TI - Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter-mediated nonquantal dopamine release JF - PHYSIOLOGICAL REPORTS J2 - PHYSIOL REPORTS VL - 9 PY - 2021 IS - 21 PG - 16 SN - 2051-817X DO - 10.14814/phy2.15088 UR - https://m2.mtmt.hu/api/publication/32503004 ID - 32503004 N1 - Export Date: 14 December 2021 LA - English DB - MTMT ER - TY - JOUR AU - Szepesy, Judit AU - Humli, Viktória AU - Farkas, János AU - Miklya, Ildikó AU - Timár, Júlia AU - Tábi, Tamás AU - Gáborján, Anita AU - Polony, Gábor AU - Szirmai, Ágnes AU - Tamás, László AU - Köles, László AU - Vizi, E. Szilveszter AU - Zelles, Tibor TI - Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice JF - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES J2 - INT J MOL SCI VL - 22 PY - 2021 IS - 6 PG - 17 SN - 1661-6596 DO - 10.3390/ijms22062853 UR - https://m2.mtmt.hu/api/publication/31923086 ID - 31923086 N1 - Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, H-1089, Hungary Department of Otorhinolaryngology, Head and Neck Surgery, Semmelweis University, Budapest, H-1083, Hungary Department of Pharmacodynamics, Semmelweis University, Budapest, H-1089, Hungary Department of Oral Biology, Semmelweis University, Budapest, H-1089, Hungary Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, H-1083, Hungary Cited By :1 Export Date: 1 February 2022 Correspondence Address: Zelles, T.; Department of Pharmacology and Pharmacotherapy, Hungary; email: zelles.tibor@med.semmelweis-univ.hu Correspondence Address: Zelles, T.; Laboratory of Molecular Pharmacology, Hungary; email: zelles.tibor@med.semmelweis-univ.hu Chemicals/CAS: selegiline, 14611-51-9, 14611-52-0, 2079-54-1, 2323-36-6; Antiparkinson Agents; Protective Agents; Selegiline Manufacturers: Chinoin Sanofi, Hungary Funding details: Emberi Eroforrások Minisztériuma, EMMI Funding details: Hungarian Scientific Research Fund, OTKA Funding details: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, NKFIH, K128875 Funding text 1: Funding: This work was supported by the Hungarian Scientific Research Fund (NKFIH, K128875) and the Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary, within the framework of the Neurology thematic program of Semmelweis University (FIKP 2020). LA - English DB - MTMT ER - TY - BOOK ED - Vizi, E. Szilveszter ED - Kabai, Sára Réka ED - Kenéz, Gabriella ED - Moravcsik-Nagy, Flóra ED - Nagy, Alexandra Hortenzia TI - Hit, tudomány és társadalom : Tanulmányok az 52. Nemzetközi Eucharisztikus Kongresszus tiszteletére = Faith, Science and Community. = Studies in Honor of the 52th International Eucharistic Congress TS - = Studies in Honor of the 52th International Eucharistic Congress PB - Szent István Társulat CY - Budapest PY - 2021 SP - 507 SN - 9789632779287 UR - https://m2.mtmt.hu/api/publication/31899222 ID - 31899222 LA - English DB - MTMT ER - TY - BOOK AU - Erdő, Péter AU - Schweitzer, József AU - Vizi, E. Szilveszter TI - Faith Morality Science PB - Dorrance Publishing Co. CY - Pittsburgh (PA) PY - 2020 SP - 242 SN - 9781644262351 UR - https://m2.mtmt.hu/api/publication/31783171 ID - 31783171 LA - English DB - MTMT ER - TY - JOUR AU - Calovi, Stefano AU - Mut-Arbona, Paula AU - Tod, Pál AU - Iring, András AU - Nicke, A. AU - Mato, S. AU - Vizi, E. Szilveszter AU - Tønnesen, J. AU - Sperlágh, Beáta TI - P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia JF - FRONTIERS IN MOLECULAR NEUROSCIENCE J2 - FRONT MOL NEUROSCI VL - 13 PY - 2020 PG - 23 SN - 1662-5099 DO - 10.3389/fnmol.2020.566251 UR - https://m2.mtmt.hu/api/publication/31778389 ID - 31778389 N1 - Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, Hungary János Szentágothai Doctoral School, Semmelweis University, Budapest, Hungary Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, Munich, Germany Achucarro Basque Center for Neuroscience, Leioa, Spain Department of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, Spain Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain Biocruces Bizkaia, Barakaldo, Spain Cited By :13 Export Date: 12 February 2024 Correspondence Address: Sperlagh, B.; Laboratory of Molecular Pharmacology, Hungary; email: sperlagh@koki.hu Chemicals/CAS: phencyclidine, 77-10-1, 956-90-1 Funding details: PPD2019-20/2019-439 Funding details: 131629, 2017-1.2.1-NKP-2017-00002 Funding details: RYC2014-15994, SAF2017-83776 Funding details: Pfizer Funding details: Horizon 2020 Framework Programme, H2020, 766124 Funding details: Deutsche Forschungsgemeinschaft, DFG, 335447717-SFB 1328 Funding details: Eusko Jaurlaritza, IT1203-19 Funding text 1: This work was supported by the Hungarian Research and Development Fund (grant number 131629), Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002 to BS), and the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skodowska Curie grant agreement No. 766124 (to BS and AN), the Deutsche Forschungsgemeinschaft (335447717-SFB 1328 to AN), and the Hungarian Academy of Sciences Premium Postdoctoral Research Program (PPD2019-20/2019-439 to AI). This work was supported by the Basque Government (IT1203-19). JT is supported by grants from the Spanish Government (RYC2014-15994; SAF2017-83776). Funding text 2: We thank László Barna, Csaba Pongor, and the NMC Imaging Center at the Institute of Experimental Medicine (IEM) for providing technical support and Anita Bagó from the Laboratory of Molecular Pharmacology of IEM for experimental assistance. We are also grateful to Christopher Gabel from Pfizer, Inc. (Groton, CT, USA) for sharing mice, and to Kornél Demeter at the Behavioral Unit of IEM for providing technical support and assisting in the behavioral experiments and the support of the Cell Biology Center (Flow Cytometry Core Facility) of IEM. Funding. This work was supported by the Hungarian Research and Development Fund (grant number 131629), Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002 to BS), and the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska Curie grant agreement No. 766124 (to BS and AN), the Deutsche Forschungsgemeinschaft (335447717-SFB 1328 to AN), and the Hungarian Academy of Sciences Premium Postdoctoral Research Program (PPD2019-20/2019-439 to AI). This work was supported by the Basque Government (IT1203-19). JT is supported by grants from the Spanish Government (RYC2014-15994; SAF2017-83776). LA - English DB - MTMT ER - TY - CHAP AU - Vizi, E. Szilveszter AU - Szabó, Csaba ED - Gyires, Klára ED - Fürst, Zsuzsanna ED - Ferdinandy, Péter ED - Pintér, Erika ED - Szilvássy, Zoltán ED - Varró, András TI - Nonadrenerg, nonkolinerg transzmisszió. Az adenozin és a nitrogén-monoxid szerepe a transtmisszióban T2 - Farmakológia és klinikai farmakológia PB - Medicina Könyvkiadó CY - Budapest SN - 9782632267388 PY - 2020 SP - 165 EP - 173 PG - 9 UR - https://m2.mtmt.hu/api/publication/31610402 ID - 31610402 LA - Hungarian DB - MTMT ER -